American College of Clinical Pharmacy
      Search      Cart

BCACP and BCGP Clinical Session -- JNC8 versus 2017 ACC/AHA Hypertension Guidelines: Which Should We Follow?

Monday, October 28, 2019 from 9:30 AM to 11:00 AM EDT at 2nd Floor: Beekman/Sutton North

Available for 1.50 hours of CPE credit
Activity Number: 0204-9999-19-303-L01-P
Activity Type: An Application-Based Activity

The BCACP and BCGP Clinical Sessions are part of the professional development program for the recertification of board-certified ambulatory care pharmacists and board-certified geriatric pharmacists, approved by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCACP and BCGP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and then must pass the associated posttest. Access to the BCACP and BCGP Clinical Sessions posttests will be available on December 18, 2019 at to anyone who has purchased access to the BCACP or BCGP posttests. For participants who have not purchased access to the posttest, access can be purchased until 5:30 p.m. on Tuesday, October 29, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be June 17, 2020.

  • Speaker: Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
    Associate Professor of Pharmacy Practice, Thomas Jefferson University, Jefferson College of Pharmacy, Philadelphia, Pennsylvania
      View Biography

  • Kristin Watson, Pharm.D., BCPSSpeaker: Kristin Watson, Pharm.D., BCPS
    Associate Professor, University Of Maryland School of Pharmacy, Baltimore, Maryland
      View Biography

Learning Objectives
1. Evaluate the recommendations for management of hypertension in adults from the eighth Joint National Committee (JNC 8) and the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines.
2. Apply the evidence-based recommendations in the current guidelines for the management of hypertension to specific patient cases, including geriatric patients.
3. In collaboration with an interprofessional team, devise pharmacotherapeutic plans for adults with hypertension based on current evidence-based guidelines and recent literature.